Injection of sterile aqueous preparations of the peptidoglycan polysaccharide of group A streptococci produces chronic inflammation in several animal models. Accordingly, the effect of peptidoglycan and group Aspecific polysaccharide (PG-APS) polymers on human polymorphonuclear neutrophil oxidative metabolism was studied with the supposition that this interaction may contribute to the inflammation observed. PG-APS in concentrations of 1.0 to 100 ,ug/ml stimulated oxygen consumption and hexose monophosphate shunt activity in the presence of 10% normal serum in a dose-related manner. Stimulation did not occur in serum-free media and was reduced in media with heat-treated serum. The stimulation of hexose monophosphate shunt activity by PG-APS opsonized with normal serum (bound complement components) and the activated supernatant from which PG-APS had been removed by centrifugation (presumably containing the soluble complement component, C5a) demonstrated 79 and 75%, respectively, of the stimulation with PG-APS in the presence of 10% normal serum. PG-APS triggered release of O2-(3.4 ± 2.0 nmol by 106 human polymorphonuclear neutrophils over 30 min), which was significantly enhanced (9.6 ± 2.9 nmol O2-) by treatment of cells with cytochalasin B. These results show that PG-APS interacts with serum in such a fashion as to activate human polymorphonuclear neutrophil metabolism and increase secretion of O2-Purified group A streptococcal cell walls consist of covalently bound polymers of peptidoglycan and group A-specific polysaccharide (PG-APS) (21). The group-specific carbohydrate moiety consists of a backbone of rhamnose with repeating epitopes of N-acetylglucosamine. The peptidoglycan moiety is made up of repeating units of the disaccharide, N-acetylglucosamine-N-acetylmuramic acid with peptide side chains bound to the muramic acid through a lactyl group on C3.
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Injection of animals with sterile aqueous preparations of PG-APS produced several models of chronic inflammation. The localization of tissue injury produced by PG-APS depends on the site of injection and the species or strain of animal: a single intradermal injection of rabbits induced recurrent multinodular lesions of the skin (32) ; intravenous or intraperitonial injection of mice resulted in a pancarditis (8) ; injection into rat gingival tissues produced periodontitis (16) ; and systemic injection of rats produced a remittant polyarthritis (7, 9) . The prolonged inflammation observed in these experimental models may result from the ability of the group A polysaccharide to protect the biologically active peptidoglycan from degradation (1, 30, 33) . The peptidoglycan moiety is responsible for inducing an inflammatory reaction characterized by vascular damage and extensive infiltration with lymphocytes, polymorphonuclear neutrophils (PMNs), and macrophages (7, 10, 25 ). The precise mechanism by which PG-APS initiates and maintains tissue injury is not known. However, a potential mechanism of tissue injury could be provided by phagocytic cells activated by ingestion of bacterial debris. The cell wall fragments persist within cultured macrophages for up to 40 days (34) and appear to be minimally degraded by PMNs (2, 3, 10, 13).
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The potential ramifications of the interaction of PG-APS with phagocytic cells have been studied only to a limited extent. Smialowicz and Schwab demonstrated a defect in phagocytosis in rat macrophages (36) and rabbit PMNs incubated with PG-APS (18) and in the activation of rat macrophages to become cytotoxic (35) . More recently, Pryzwansky et al. (26) [1-14C]glucose was obtained from New England Nuclear Corp. (Boston, Mass.). Zymosan (Sigma) was prepared in HBSS each day. Dimethyl sulfoxide was obtained from Sigma. Cytochalasin B was purchased from Sigma, dissolved in dimethyl sulfoxide to a concentration of 1 mg/ml, and frozen at -20°C. Fresh samples were thawed before use each day. Previous work has shown that neither cytochalasin B or dimethyl sulfoxide in the concentrations used interfered with assays or cell survival (28) .
Bacterial cell wall preparation. The details of the bacterial cell wall preparation have been described (12 (29) . 14Co2 was collected in alkali and measured in a liquid scintillation counter (29) .
Statistics. (Fig. 3) . Cytochalasin B prevents phagosome closure and thereby enhances recovery of O2 formed, which would normally be trapped in phagocytic vacuoles (19, 28) . Cell preparations were preincubated with 5 pug of cytochalasin B per ml for 5 min before use. Under these conditions, 13.4 + 4.5 nmol of 02 was consumed (n = 4), and 9.6 ± 2.9 nmol (72% of 02 consumed) of O2 was recovered per 106 cells (Fig. 3) . These (14) . Alternatively, PG-APS may be opsonized by C3b and stimulate the PMN by binding to C3b receptors (26) ; furthermore, both mechanisms may occur simultaneously. Accordingly, a preparation of 100p60 PG-APS particles (prepared by ultracentrifugation at 100,000 x g) was preopsonized with 50% normal serum.
After incubation with serum, the PG-APS was centrifuged at 100,000 x g, and the supernatant was then removed and stored at -70°C. Both PG-APS preopsonized with normal serum (pellet from 100,000 x g) as well as nents) stimulated HMS activity ( Table 2 ). The stimulation by preopsonized PG-APS and supernatant was 100 and 70%, respectively, of the stimulation observed with PG-APS in the presence of serum. The first wash material lost activity with time when frozen at -70°C (data not shown).
DISCUSSION
A single injection of an aqueous suspension of group A streptococcal cell wall (PG-APS) produces chronic, remittant inflammation in the joints, heart, intestine, or skin; the location of lesions depends on the animal species and injection route (3i). In the early phase of the inflammatory reaction and during exacerbations, PMNs are observed within the lesion (10) . However, no previous studies have been performed to investigate the effects of PG-APS on PMN function, although these cells could be involved in the tissue injury associated with PG-APS administration.
Accordingly, we studied the effects of PG-APS on neutrophil oxidative metabolism. The PMN responds to perturbations of the plasma membrane with a burst of oxygen consumption, increased HMS activity, and formation of microbicidal oxygen reduction products (20) . Our results show that PG-APS does, not stimulate PMN oxygen consumption or oxidition of [1-14C] glucose in the absence of Ferum. However, in the presence of 10% normal serum, a concentration of PG-APS between 1.0 to 50.0 ,ug/ml leads to significant stimulation of PMN 02 consumption and glucose oxidation, with maximal effect of PG-APS at 50 ,ug/ml. PMN activation by PG-APS was markedly reduced when heatinactivated serum was used, suggesting that complement or other heat-labile factors are of greatest importance. Greenblatt and co-workers reported activation of the alternate complement pathway in human serumh by peptidoglycan and cell wall preparations of group A streptococci (15) . In addition, with a flourescent antibody technique, Pryzwansky et al. observed binding of PG-APS opsonized with normal serum or C3b (26) . Their study also showed that binding did not occur in the absence of fresh serutm or when heqtinactivated serum was used (26) . However, the residual stimulation of O2 release by PG-APS in heat-inactivated serum suggests that under these conditions, antibody may directly mediate some binding or lead to an aggregation of PG-APS sufficient to allow membrane perturbation or phagocytosis.
These results suggested that complement actiVation by PG-APS could stimulate PMN oxidative metabolism either by opsonization of PG-APS (26) and subsequent binding to the neutrophil surface or through the formation of C5a, a soluble complement component which stimulates the PMN respiratory burst and degranulation (14) . To address these alternativb mechanisms, a homogeneous preparation of PG-APS (100p60) which can be pelleted out of serum by ultracentrifugation (5) was employed. Both the opsonized 100p60 PG-APS fragments as well as the activated (PG-APS-free) serum lead to PMN stimulation, suggesting that more than one mechanismn was operative.
The products of PMN oxidativl metabolism (superoxide anion, hydrogen peroxide, and hydroxyl radicals) are reduction products which have both mlcrobicidal and cytotoxic properties (20) . Leakage or secretion of these toxic oxygen reduction products leads to tissue damage and contributes to the pathogenesis of inflammation (19) . Previous studies have shownl that only a small portioh of the oxygen consumed during phagocytosis of opsonized particles is recovered as 02 unless the cells are pretreated with cytochalasin B to inhibit phagosome closure (28) . However, in response to phorbol myristate acetate, a soluble triggering agent, 02 iS secreted into the extracellular space rather than into phagocytic vacuoles (22) . Extracellular secretion of oxygen radicals enhances tumor lysis (23) and could potentially promote tissue damage, either directly or by interfering with antiproteases important in control of chronic ihflammation (17) . During recent studies of the microscopic interaction of PG-APS with human PMNs, PryzWansky et al. (26) noted neutrophil capping, a morphological configuration most consistent with microtubular disaggregation (24) . These results suggested the possibility of an alternative mode of secretion of O2 reduction products in response to PG-APS which might favor tissue inflammation. To examine this possibility, we studied the stoichiometry of 02 consumption with respect to O2 release by PG-APS-stimulated PMNs. In the absence of cytochalasin B, the O2 recovered represented only 20% of the oxygen consumed. When cells were pretreated with cytochalasin B, PG-APS-stimulated O2 release increased to 72% of the 02 consumed. Cytochalasin B reduced overall 02 consumption to 68% of the untreated PG-APS-stimulated control. Similar rediuctions in oxygen consumption by cytochalasin B with opsonized particles have been observed, presumably as a consequence of decreased stimulus (particle) binding to the cells (6, 27, 28 ). Our results demonstrate that most of the O2 formed by PG-APS stimulation is localized into phagocytic vacuoles, and maximal recovery of 02 is demonstrated only after phagosome formation is inhibited, which suggests that PG-APS is handled by the cell in a manner similar to other phagocytic stimuli.
The observations reported are consistent with the concept 
